Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 265/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Applied in pharmaceutical field, Azithromycin can be used for respiratory tract infections, urinary tract in fections, skin and soft tissue infections and sexually transmitted diseases; It also to be effective against lateonset asthma, but these findings are controversial and not widely accepted.
Product Name
|
Azithromycin |
CAS
|
83905-01-5 |
Appearance
|
White crystalline Powder |
MF
|
C38H72N2O12 |
Molecular Weight
|
748.984 |
Purity
|
99%
|
Storage
|
Keep in a cool, dry, dark location in a tightly sealed container or cylinder
|
Shelf Life
|
24 Months
|
Items | Specifications | Results |
Appearance | White or almost white crystalline powder | White crystalline powder |
Solubility | Practically insoluble in water, freely soluble in anhydrous ethanol and in methylene chlorid | Conforms |
Idetification | 1) IR: Conforms to the spectrum of Azithromycin RS | Conforms |
2) HPLC: The retention time of azithromycin peak in the chromatogram of the assay preparation corresponds to that in the chromatogram of the Standard preparation, as ovtained in the assay |
||
Specific rotation | -45°~ -49° | -47° |
Crystallinity | Meets the requirements | Conforms |
pH | 9.0~11.0 (2mg/ml methanol-water(1:1)) | 10.1 |
Water | 4.0%~5.0% | 4.60% |
Residue on ignition | ≤0.3% | 0.01% |
Heavy metals | ≤25ppm | <25ppm |
Impurity A ≤0.5% | Not detected | |
Impurity B ≤1.0% | 0.40% | |
Impurity C ≤0.5% | 0.22% | |
Impurity J ≤0.3% | 0.11% | |
Impurity E ≤0.5% | Not detected | |
Impurity F ≤0.5% | <0.10% | |
Impurity G ≤0.5% | Not detected | |
Related Substances(HPLC Test 2) | Impurity I ≤0.7% | Not detected |
Impurity L≤0.5% | Not detected | |
Impurity M≤0.5% | Not detected | |
Impurity N ≤0.5% | Not detected | |
Impurity O≤0.5% | 0.11% | |
Impurity P ≤0.2% | <0.10% | |
Any other impuirty ≤0.2% | <0.10% | |
Total impurities ≤3.0% | 0.84% | |
Residual Solvents | Methylene Chlorde≤600ppm | Not detected |
Aceton ≤5000ppm | 330ppm | |
Assay | 945~1030μg/mg (Anhydrous substance ) | 978μg/mg |
Conclusion | The results can conforms with the USP37 standard. |
1. Azithromycin is used to treat or prevent certain bacterial infections, most often those causing middle ear i nfections, strep throat, pneumonia, typhoid, and sinusitis;
2. It has been used primarily to prevent bacterial infections in infants and those with weaker immune system
3. It is also effective against certain sexually transmitted infections, such as non- gonococcal urethritis, chlamydia, and cervicitis;
4. Azithromycin is used for acute pharyngitis, acute tonsillitis caused by Streptococcus pyogenes;
5. Azithromycin is used for acute throat and tonsillitis which are caused by streptococcus pyogenes, otitis;
6. Azithromycin can treatment of media sinusitis acute bronchitis skin soft tissue infection which are caused by sensitive bacteria;
7. Azithromycin is also used for pneumonia urethritis cervicitis and so on.
Name | CAS No. | Purity |
Sunifiram | 314728-85-3 | 99.0% |
Unifiram | 272786-64-8 | 99.0% |
Idebenone | 58186-27-9 | 99.0% |
Pramiracetam | 68497-62-1 | 99.0% |
Fasoracetam | 110958-19-5 | 99.0% |
Oxiracetam | 62613-82-5 | 99.0% |
Phenylpiracetam hydrazide | 77472-71-0 | 99.0% |
Galantamine Hydrobromide | 69353-21-5 | 98.0% |
Tianeptine | 66981-73-5 | 99.0% |
Tianeptine sodium | 30123-17-2 | 99.0% |
Tianeptine hemisulfate monohydrate (THM) | 1224690-84-9 | 99.0% |
9-ME-BC(9-Methyl-9H-beta-carboline) | 2521/7/5 | 99.0% |
Agomelatine | 138112-76-2 | 99.0% |
6-Paradol 98% | 27113-22-0 | 98% Oil form |
6-Paradol 50% | 27113-22-0 | 50% Powder form |
Nicotinamide Riboside Chloride(NRC) | 23111-00-4 | 98.0% |
Beta-Nicotinamide Mononucleotide(NMN) | 1094-61-7 | 99.0% |
β-Nicotinamide Adenine Dinucleotide(NAD+) | 53-84-9 | 98.0% |
Noopept,GVS-111 | 157115-85-0 | 99.0% |
Piracetam | 7491-74-9 | 99.0% |
Phenibut | 1078-21-3 | 99.0% |
Coluracetam | 135463-81-9 | 99.0% |
N-Methyl-D-aspartic acid(NMDA) | 6384-92-5 | 99.0% |
Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 99% Powder form |
Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 50% Graininess form |
Citicoline | 987-78-0 | 99.0% |
PRL-8-53 | 51352-87-5 | 98.0% |
NSI-189 Phosphate | 1270138-41-4 | 99.0% |